First human myoblast transfer therapy continues to show dystrophin after 6 years.

Cell transplantation

Volumn 6, Issue 1, 1997, Pages 95-100

  Law, P K ^a   Goodwin, T G ^a   Fang, Q ^a   Hall, T L ^a   Quinley, T ^a   Vastagh, G ^a   Duggirala, V ^a   Larkin, C ^a   Florendo, J A ^a   Li, L ^a   Jackson, T ^a   Yoo, T J ^a   Chase, N ^a   Neel, M ^a   Krahn, T ^a   Holcomb, R ^a  

^a Cell Transplants International LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DYSTROPHIN;

ARTICLE; CASE REPORT; CHILD; CYTOLOGY; FOLLOW UP; GENE THERAPY; GENE TRANSFER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MUSCLE; MUSCULAR DYSTROPHY; TRANSPLANTATION;

CHILD; CYCLOSPORINE; DYSTROPHIN; FOLLOW-UP STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLES; MUSCULAR DYSTROPHIES;

MLCS; MLOWN;

EID: 0030636432     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0963-6897(96)00138-8     Document Type: Article

References (0)